Medical device players still do not tackle China’s elderly patients head-on  - yet it provides huge opportunities in disease management (e.g. for chronic diseases such as high blood pressure and diabetes) with annual growth rates of 30%+.

Find out how medtech companies developed successful approaches to reach a quarter billion elderly patients in China.